Skip to main content

U.S. Stem Cell, Inc.

USRMDelisted
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001388319

U.S. Stem Cell, Inc. was delisted in 2026; its insiders filed their last Form 4 on Apr 29, 2022; 1 institution reported holding it in 13F filings for Q2 2026, worth $11 in total; no superinvestor held it.

Superinvestors holding USRM, Q2 2026

See all superinvestors

No superinvestor reported holding USRM in Q2 2026.